21 C.F.R. § 862.1685

Thyroxine-binding globulin test system.

Last amended: 2019Year: 2026Length: 88 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 862.1685 (2026)

(a) Identification. A thyroxine-binding globulin test system is a device intended to measure thyroxine (thyroid)-binding globulin (TBG), a plasma protein which binds thyroxine, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of thyroid diseases. (b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9. [52 FR 16122, May 1, 1987, as amended at 84 FR 71797, Dec. 30, 2019]
Cross-references to the CFR
862.9.
21 C.F.R. § 862.1685: Thyroxine-binding globulin test system. | Justis AI